Dr. Francois Lamontagne, MD
Claim this profileCentre Hospitalier Universitaire de Sherbrooke
Studies Coronavirus
Studies Pneumonia
7 reported clinical trials
76 drugs studied
Affiliated Hospitals
Clinical Trials Francois Lamontagne, MD is currently running
Multiple Treatments
for Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of multiple treatment modalities in the event of a respiratory pandemic such as COVID-19. REMAP-COVID is a sub-platform of REMAP-CAP that evaluates treatments specific to COVID-19 in the United States of America.
Recruiting2 awards Phase 33 criteria
Heparin
for Community-Acquired Pneumonia
This trial is testing if higher doses of heparin, a blood thinner, can help patients hospitalized with pneumonia. These patients often have blood clot complications that worsen their condition. By preventing these clots, heparin might improve their recovery and reduce severe outcomes. Heparin has been shown to reduce the risk of blood clots in various patients, including those hospitalized for medical conditions and surgeries.
Recruiting2 awards Phase 35 criteria
More about Francois Lamontagne, MD
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Francois Lamontagne, MD has experience with
- Interferon Beta-1a
- Pantoprazole
- Placebo (0.9% Saline)
- Dexamethasone
- LSALT Peptide
- Artesunate
Breakdown of trials Francois Lamontagne, MD has run
Coronavirus
Upper Gastrointestinal Bleeding
Gastrointestinal Bleeding
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Francois Lamontagne, MD specialize in?
Francois Lamontagne, MD focuses on Coronavirus and Pneumonia. In particular, much of their work with Coronavirus has involved treating patients, or patients who are undergoing treatment.
Is Francois Lamontagne, MD currently recruiting for clinical trials?
Yes, Francois Lamontagne, MD is currently recruiting for 2 clinical trials in Sherbrooke Quebec. If you're interested in participating, you should apply.
Are there any treatments that Francois Lamontagne, MD has studied deeply?
Yes, Francois Lamontagne, MD has studied treatments such as Interferon beta-1a, Pantoprazole, Placebo (0.9% saline).
What is the best way to schedule an appointment with Francois Lamontagne, MD?
Apply for one of the trials that Francois Lamontagne, MD is conducting.
What is the office address of Francois Lamontagne, MD?
The office of Francois Lamontagne, MD is located at: Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec J1H 5N4 Canada. This is the address for their practice at the Centre Hospitalier Universitaire de Sherbrooke.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.